Latest Breaking News On - Nd nrsn il0011809592 - Page 1 : comparemela.com

In May 2023, NeuroSense Therapeutics Ltd. entered into a strategic business and scientific collaboration with a leading global biotechnology company that pioneers science and drives. | May 25, 2023

Neurosense therapeutics ltdNeurosense therapeuticsRegistration statementsNeurosense therapeutics ltd stock exchangePress releaseNd nrsn il0011809592